REBEKAH WATSON: Open Payments
NPI 1417535188 · MARATHON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 19 payments from 12 companies in 2025. Trend: 2023 $1,586 · 2024 $1,758 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $548 |
| Boston Scientific Corporation | 1 | $149 |
| Novo Nordisk Inc | 1 | $125 |
| ABIOMED | 1 | $120 |
| Amgen Inc. | 1 | $82 |
| Merck Sharp & Dohme LLC | 2 | $65 |
| Insmed, Inc. | 2 | $43 |
| Corcept Therapeutics | 1 | $27 |
| Exact Sciences Corporation | 1 | $19 |
| Dexcom, Inc. | 1 | $17 |
Products named: BREZTRI, WATCHMAN FLX, TEZSPIRE, Ozempic, AIRSUPRA, REPATHA, ZERBAXA, FARXIGA.
Industry payments across FL — which companies pay providers there.
